Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs.
Can we protect drug users from hepatitis C?
Non-buprenorphine opioid utilization among patients using buprenorphine.
Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Can we protect drug users from hepatitis C?
Can we protect drug users from hepatitis C? J Policy Anal Manage. 2001 Apr; 20(2):358-64.
View in:
PubMed
subject areas
Hepatitis C
Humans
Models, Theoretical
Needle Sharing
Needle-Exchange Programs
Policy Making
Substance-Related Disorders
United States
authors with profiles
Harold A. Pollack